APTIVUS 250 mg, capsule molle — 1 flacon(s) polyéthylène haute densité (PEHD) de 120 capsule(s) avec fermeture de sécurité enfant
Medicine package · Base de données publique des médicaments (BDPM), ANSM, HAS et Assurance Maladie · France
-
CIP13
3400936925243 -
CIP7
3692524 -
CIS
67219072 -
Registration number
EU/1/05/315
What the source publishes
- Holder
- BOEHRINGER INGELHEIM INTERNATIONAL
- Active ingredients
- TIPRANAVIR
- Form
- capsule molle
- Package
- 1 flacon(s) polyéthylène haute densité (PEHD) de 120 capsule(s) avec fermeture de sécurité enfant
- Routes
- orale
- Administrative status
- authorised
- Supply regime
- prescription initiale hospitalière annuelle ; liste I ; renouvellement non restreint
- Marketing status
- Déclaration de commercialisation
- Authorised on
- 2005-10-25
- Prescription
- Prescription or restricted
Names this record is found by
- APTIVUS 250 mg, capsule molle — 1 flacon(s) polyéthylène haute densité (PEHD) de 120 capsule(s) avec fermeture de sécurité enfant
- APTIVUS 250 mg, capsule molle
- TIPRANAVIR
Complete source data
{
"cis": "67219072",
"cip7": "3692524",
"form": "capsule molle",
"name": "APTIVUS 250 mg, capsule molle — 1 flacon(s) polyéthylène haute densité (PEHD) de 120 capsule(s) avec fermeture de sécurité enfant",
"cip13": "3400936925243",
"holder": "BOEHRINGER INGELHEIM INTERNATIONAL",
"routes": [
"orale"
],
"holders": [
"BOEHRINGER INGELHEIM INTERNATIONAL"
],
"currency": "EUR",
"marketed": true,
"bdmStatus": null,
"useDomain": "unknown",
"publicPrice": "798.11",
"authorisedOn": "2005-10-25",
"compositions": [
{
"name": "TIPRANAVIR",
"nature": "SA",
"strength": "250 mg",
"linkageNumber": "1",
"substanceCode": "44704",
"dosageReference": "une capsule",
"pharmaceuticalElement": "capsule"
}
],
"sourceStatus": "Présentation active",
"supplyRegime": "prescription initiale hospitalière annuelle ; liste I ; renouvellement non restreint",
"dispensingFee": "1.02",
"medicinePrice": "797.09",
"regionalRules": "not-collected",
"targetSpecies": [],
"specialityName": "APTIVUS 250 mg, capsule molle",
"marketingStatus": "Déclaration de commercialisation",
"publicationDates": {
"CIS_bdpm": "2026-01-08",
"CIS_CIP_bdpm": "2026-11-19",
"CIS_CPD_bdpm": "2026-01-08",
"CIS_COMPO_bdpm": "2026-01-08"
},
"specialityListed": true,
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "fr.ansm.bdpm"
},
"collectiveApproval": "oui",
"packageDescription": "1 flacon(s) polyéthylène haute densité (PEHD) de 120 capsule(s) avec fermeture de sécurité enfant",
"patientEligibility": "not-assessed",
"reimbursementRates": [
"100%"
],
"marketingDeclaredOn": "2005-12-15",
"targetSpeciesStatus": "not-reported",
"additionalMonitoring": false,
"administrativeStatus": "authorised",
"prescriptionCategory": "prescription-or-restricted",
"activeIngredientNames": [
"TIPRANAVIR"
],
"authorisationProcedure": "Procédure centralisée",
"prescriptionConditions": [
"prescription initiale hospitalière annuelle",
"liste I",
"renouvellement non restreint"
],
"reimbursementIndications": null,
"authorisationSourceStatus": "Autorisation active",
"europeanAuthorisationNumber": "EU/1/05/315",
"presentationAdministrativeStatus": "authorised"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=fr" \
--data-urlencode "sourceId=fr.ansm.bdpm" \
--data-urlencode "id=fr:ansm:packages:3400936925243"